Cynthia Collins Poseida Therapeutics, Inc. (PSTX) insider trading activity

PSTX Quotes by TradingView

Cynthia Collins is of Poseida Therapeutics, Inc.. Currently has a direct ownership of 58,950 shares of PSTX, which is worth approximately $160,933. The most recent transaction as insider was on Jun 17, 2024, when has been sold 19,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59K
0% 3M change
50.0% 12M change
Total Value Held $160,933

Cynthia Collins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2024
BUY
Grant, award, or other acquisition
-
19,650 Added 25.0%
58,950 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
19,650 Added 33.33%
39,300 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
19,650 Added 50.0%
19,650 Common Stock

Also insider at

EDIT
Editas Medicine, Inc. Healthcare
CEO
DMTK
DermTech, Inc. Healthcare
Director
CERT
Certara, Inc. Healthcare
MXCT
MAXCYTE, INC. Healthcare
CC

Cynthia Collins

Princeton, NJ

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PSTX